Anna Plotkin
Oshawa, ON L1G2B9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
HER2 Expression in Squamous Cell Carcinoma of the Vulva: A Systematic Review and Meta-Analysis.
Journal: Cancers
Published: April 05, 2026
Evaluating HER2 Scoring Criteria in Endometrial Carcinoma: Gynecologic Versus Gastric Guidelines for Trastuzumab and Trastuzumab-Deruxtecan Selection.
Journal: Cancers
Published: March 16, 2026
Clinicopathologic Features and Genomic Profile of Human Epidermal Growth Factor Receptor 2-Low and Human Epidermal Growth Factor Receptor 2-Ultralow Invasive Breast Carcinomas.
Journal: Archives of pathology & laboratory medicine
Published: August 19, 2025
International Feasibility of Applying Diagnostic Essential Criteria of the Fifth Edition World Health Organization Classification of Female Genital Tumors: Evidence for a Global Gap in Health Care Equity.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: December 02, 2024
Advances in Vulvar Cancer Biology and Management.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 31, 2024
Analytical Validation and Performance Evaluation of Amplicon-Based Next-Generation Sequencing Assays for Detecting ERBB2 and Other Gene Amplifications in Solid Tumors.
Journal: Cancers
Published: October 21, 2024
Implementation of HER2 Testing in Endometrial Cancer, a Summary of Real-World Initial Experience in a Large Tertiary Cancer Center.
Journal: Cancers
Published: April 30, 2024
Human Epidermal Growth Factor Receptor 2-Low Breast Cancer Brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population.
Journal: JCO precision oncology
Published: March 28, 2024
Fit-for-Purpose Ki-67 Immunohistochemistry Assays for Breast Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: November 22, 2023
Budget impact analysis of molecular subtype profiling in endometrial cancer.
Journal: Gynecologic oncology
Published: June 28, 2023
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force.
Journal: Current oncology (Toronto, Ont.)
Published: February 02, 2023
Last Updated: 09/26/2026